IA-based VIDA Diagnostics Inc. has informed that its primary product, Pulmonary Workstation 2.0 (PW2) has obtained FDA 510(k) clearance for sale.

The company stated in a communiqué that, PW2 is the first commercial release of lung image analysis software from VIDA and comprises a comprehensive approach to quantitative, repeatable lung measurements including the industry's first so-approved automatic lobe density and airway system measurement functions.

VIDA's PW2 takes the complex information from a CT (computed tomography) scan of the lung and converts it into useful 3D images and measurements that are easily viewed by the practicing pulmonologist at the point of patient service, or by the radiologist in the radiology department, the release further added.

VIDA Diagnostics, Inc. is the leader in pulmonary image analysis and therapy planning. The company develops and markets software solutions that unlock the power of high-resolution computerized tomography (CT) image data sets of the lung.